The new cooperation agreement announced in a joint press release 18th of December is an extension of the partnership that the two national initiatives formalized in 2022. As part of the new agreement, GMS and DNGC will collaborate on a number of key areas, including:
- Standardization, quality assurance and validation of genetic analyses.
- National bioinformatics platforms for secure storage and sharing of data.
- Economic models and participation in European initiatives such as 1+ Million Genomes and Genome of Europe.
- Clinical decision support systems and tools that can identify patient groups who will benefit the most from whole-genome sequencing.
- Engagement of patients, healthcare professionals and the public through information and education.
“Knowledge sharing between Denmark and Sweden has been valuable in understanding how the development and integration of methods such as Next Generation Sequencing* and processes in, for example, clinical practice, as well as within precision medicine research, can be advanced. Experiences from genome initiatives like the Danish National Genome Center and from other countries further prepare us to address challenges such as data access, public-private collaboration, health economics and much more.” – Richard Rosenquist Brandell, Director of Genomic Medicine Sweden.
“The agreement with Genomic Medicine Sweden emphasizes the importance of close collaboration between the Swedish and Danish initiative to ensure a coordinated approach and the development of tangible solutions. The partnership marks a significant milestone in our joint efforts, where the exchange of knowledge and experiences across borders creates synergies that will benefit patients in both countries.” – Bettina Lundgren, CEO of the Danish National Genome Center.